All Episodes

75. Contingency Management for Stimulant Use and Mortality

74. Quick-Start Injectable Buprenorphine

Articles That Changed Our Practice 2026 (Part 2)

Articles That Changed Our Practice 2026 (Part 1)

73. Long-Term Opioid Use After a First Prescription

72. Symptom-Triggered Alcohol Withdrawal Management Over Telemedicine

71. Buprenorphine and Dental Problems

61-70 Round-Up

70. Prescription Stimulant Misuse

69. Cytisinicline for Smoking Cessation

68. Behavioral Treatments as an Adjunct to Buprenorphine

67. Rapid-Start Injectable Buprenorphine

66. Smoking in Recovery

65. Varenicline and Bupropion for Alcohol Use Disorder

64. Screen Addiction and Suicide

51-60 Round-Up

Keeping up with the Addiction Medicine Literature

63. Buprenorphine Dose and Neonatal Opioid Withdrawal

62. Naltrexone Pills vs Injections for Alcohol Use Disorder

61. Safety of BuprenorphineNaloxone vs. Buprenorphine in Pregnancy

60. Lisdexamfetamine for methamphetamine use disorder

59. Low-Dose Buprenorphine Initiation (Micro-induction)

58. Semaglutide for Alcohol Use Disorder (RCT)

Articles That Changed Our Practice 2025 (Part 2)

Articles That Changed Our Practice 2025 (Part 1)

57. What is Recovery?

56. How Many Quit Attempts Does It Take

55. How Buprenorphine Works in Pregnancy

54. High Daily Doses of Buprenorphine

53. Methadone Vs. Buprenorphine

52. Buprenorphine-precipitated Fentanyl Withdrawal

51. Fun Activities and Recovery

41-50 Round-Up

50. Kratom Journal Club

49. Naltrexone/Bupropion for Methamphetamine Use Disorder

Kratom: At Least It’s Not Fentanyl

48. Semaglutide and Alcohol Use Disorder

47. Injectable Vs. Sublingual Buprenorphine for Fentanyl Use Disorder

46. High Dose Meds for Smoking Cessation

45. Urine Drug Screens and Treatment Retention

44. Cannabis and CV Outcomes

43. Alcohol Use Disorder Meds at Hospital Discharge

42. The Protective Effect of Buprenorphine

41. Vaping for Smoking Cessation

31-40 Round-Up

40. BZD Prescriptions and Overdose Risk

39. Opioid Abstinence and Cognitive Function

Articles that Changed Our Practice - Part 2

Articles that Changed Our Practice - Part 1

38. Rehab vs. Meds vs. No Treatment

37. Injectable Vs. Sublingual Buprenorphine

36. FOMO and Smartphone Use

35. Prior Auths and Buprenorphine

34. 24 mg of Buprenorphine

33. Polypharmacy and Overdose

32. Trazodone for Sleep in OUD

31. Naloxone and IV Drug Use

21-30 Round-Up

30. Race and MOUD

29. Vaping Cessation

28. Pain and Recovery

27. The First Opioid Prescription

26. Addiction Survivors

25. High-dose Buprenorphine Induction

24. Smoking Cessation and Mortality

23. Eat-Sleep-Console

22. Contingency Management for Coronary Artery Disease

21. SOAT for OUD: Short-Acting Opioid Agonists for Opioid Use Disorder

What We Learned at ASAM2023

11-20 Round-up

20. Targeted Naltrexone for Binge Drinking

19. Patients’ Goals in Treatment

18. Treating HCV in People Who Inject Drugs

17. Bup-nalox vs. Bup in Pregnancy

16. Treating Opioid Use Disorder in Jail

15. Buprenorphine vs. Methadone in Pregnancy

14. Early Life Trauma and Opioid Use Disorder

13. Prescription Opioids and Cognitive Decline

12. Methamphetamine and Opioid Overdose in Rural Communities

11. Wine Bottle and Wineglass Size

1-10. Round-up

10. Buprenorphine Tapering

9. Psilocybin for Alcohol Use Disorder

8. Opioid Tapering and Risk of Suicide and Overdose

7. Treating Opioid and Polysubstance Use Disorders

6. A BZD-Sparing Alcohol Withdrawal Protocol

5. Clinical Effects of Medical Marijuana Cards

4. Smoking Cessation After Lung Cancer Diagnosis

3. Opioid Tapering and Overdoses and Mental Health Crises

2: Prescribing Stimulants for Patients on Buprenorphine

1. The Cardiovascular Effects of Alcohol